Match!

Characteristics of finasteride users in comparison with nonusers: A Nordic nationwide study based on individual-level data from Denmark, Finland, and Sweden.

Published on Feb 11, 2020in Pharmacoepidemiology and Drug Safety2.87
· DOI :10.1002/PDS.4947
Thora Majlund Kjærulff3
Estimated H-index: 3
(University of Southern Denmark),
Annette Kjær Ersbøll35
Estimated H-index: 35
(University of Southern Denmark)
+ 6 AuthorsLau Caspar Thygesen22
Estimated H-index: 22
(University of Southern Denmark)
Abstract
PURPOSE: Published epidemiological studies on the association between finasteride use and the risk of male breast cancer have been inconclusive due to methodological limitations including a few male breast cancer cases included. Determinants of male breast cancer have been studied, but it remains unexplored whether these are also related to finasteride use and thereby constitute potential confounders. This study aimed to assess whether there are differences between finasteride users and nonusers with regard to numerous potential confounders. METHODS: In total, 246 508 finasteride users (>/=35 years) were identified in the prescription registries of Denmark (1995-2014), Finland (1997-2013), and Sweden (2005-2014). An equal number of nonusers were sampled. The directed acyclic graph (DAG) methodology was used to identify potential confounders for the association between finasteride and male breast cancer. A logistic regression model compared finasteride users and nonusers with regard to potential confounders that were measurable in registries and population surveys. RESULTS: Finasteride users had higher odds of testicular abnormalities (odds ratio [OR] 1.40; 95% confidence interval [CI] 1.36-1.44), obesity (1.31; 1.23-1.39), exogenous testosterone (1.61; 1.48-1.74), radiation exposure (1.22; 1.18-1.27), and diabetes (1.07; 1.04-1.10) and lower odds of occupational exposure in perfume industry or in high temperature environments (0.93; 0.87-0.99), living alone (0.89; 0.88-0.91), living in urban/suburban areas (0.97; 0.95-0.99), and physical inactivity (0.70; 0.50-0.99) compared to nonusers. CONCLUSIONS: Systematic differences between finasteride users and nonusers were found emphasizing the importance of confounder adjustment of associations between finasteride and male breast cancer.
  • References (24)
  • Citations (0)
📖 Papers frequently viewed together
4 Citations
219 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References24
Newest
#1Thora Majlund Kjærulff (University of Southern Denmark)H-Index: 3
#2Annette Kjær Ersbøll (University of Southern Denmark)H-Index: 35
Last. Lau Caspar Thygesen (University of Southern Denmark)H-Index: 22
view all 9 authors...
Source
#1Mathias Meijer (University of Southern Denmark)H-Index: 5
#2Lau Caspar Thygesen (University of Southern Denmark)H-Index: 22
Last. Annette Kjær Ersbøll (University of Southern Denmark)H-Index: 35
view all 10 authors...
4 CitationsSource
#1Eero Pukkala (UTA: University of Tampere)H-Index: 91
#2Gerda EngholmH-Index: 44
Last. Samera Azeem QureshiH-Index: 61
view all 15 authors...
AbstractBackground: The Nordic Cancer Registries are among the oldest population-based registries in the world, with more than 60 years of complete coverage of what is now a combined population of 26 million. However, despite being the source of a substantial number of studies, there is no published paper comparing the different registries. Therefore, we did a systematic review to identify similarities and dissimilarities of the Nordic Cancer Registries, which could possibly explain some of the ...
45 CitationsSource
#2Hozefa A DivanH-Index: 2
Last. Susan S. JickH-Index: 63
view all 5 authors...
10 CitationsSource
#1Morten Schmidt (Aarhus University Hospital)H-Index: 27
#2Jesper Hallas (University of Southern Denmark)H-Index: 48
Last. Søren Friis (Aarhus University Hospital)H-Index: 7
view all 4 authors...
33 CitationsSource
#1Thora Majlund Kjærulff (University of Southern Denmark)H-Index: 3
#2Annette Kjær Ersbøll (University of Southern Denmark)H-Index: 35
Last. Lau Caspar Thygesen (University of Southern Denmark)H-Index: 22
view all 11 authors...
AbstractObjective Finasteride 5 mg is a drug used to treat prostate hyperplasia. Little is known about its pattern of usage. This cross-national analysis of individual-level data from Denmark, Finland, Norway and Sweden was undertaken to appraise its usage and describe cross-national differences. Materials and methods Individual-level data from nationwide prescription registers in Denmark (1995–2009), Finland (1997–2010), Norway (2004–2009) and Sweden (July 2005–2011) were used to examine cross-...
2 CitationsSource
Background The Danish National Patient Registry (DNPR) is one of the world’s oldest nationwide hospital registries and is used extensively for research. Many studies have validated algorithms for identifying health events in the DNPR, but the reports are fragmented and no overview exists.
702 CitationsSource
#1David Robinson (Umeå University)H-Index: 100
#2Hans Garmo (Uppsala University Hospital)H-Index: 39
Last. Pär Stattin (Umeå University)H-Index: 71
view all 4 authors...
Purpose 5-α reductase inhibitors (5-ARI) have been suggested to increase the risk of male breast cancer. The aim of this study was to study the risk of breast cancer in men on 5-ARI, in men with benign prostatic hyperplasia (BPH) not on 5-ARI, and in men without BPH.
6 CitationsSource
#1Ruben G. Duijnhoven (UU: Utrecht University)H-Index: 5
#2Sabine M. J. M. Straus (Erasmus University Medical Center)H-Index: 10
Last. Marie L. De Bruin (UU: Utrecht University)H-Index: 24
view all 7 authors...
Background The 5α-reductase inhibitors (5-ARI) finasteride and dutasteride are indicated for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia. Case reports have suggested that 5-ARIs increase the risk for male breast cancer, with no conclusive evidence. The objective of this study was to quantify the association between use of 5-ARIs and the risk for male breast cancer.
20 CitationsSource
#1Louise A. Brinton (NIH: National Institutes of Health)H-Index: 107
#2Michael B. Cook (NIH: National Institutes of Health)H-Index: 37
Last. David B. Thomas (Fred Hutchinson Cancer Research Center)H-Index: 40
view all 36 authors...
The etiology of male breast cancer is poorly understood, partly because of its relative rarity. Although genetic factors are involved, less is known regarding the role of anthropometric and hormonally related risk factors.
61 CitationsSource
Cited By0
Newest